Life with chronic pain during COVID-19 lockdown: the case of patients with small fibre neuropathy and chronic migraine

Consonni, Monica; Telesca, Alessandra; Grazzi, Licia; Cazzato, Daniele; Lauria, Giuseppe

doi:10.1007/s10072-020-04890-9

Cited by 32 publications

(56 citation statements)

References 39 publications

(48 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several studies have investigated the influence of lockdown on the behaviour and habits of individuals with migraine and have explored ways in which the new circumstances have altered exposure to typical migraine triggers and migraine-aggravating behaviours 1 – 4 . Interestingly, the results of a recent study by Verhagen et al 1 suggest that, in some ways, the change in lifestyle caused by the pandemic has been beneficial for individuals with migraine.…”

mentioning

confidence: 99%

Lessons from lockdown — behavioural interventions in migraine

Grazzi¹,

Rizzoli

2021

Nat Rev Neurol

Self Cite

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Lessons from lockdown — behavioural interventions in migraine

Grazzi¹,

Rizzoli

2021

Nat Rev Neurol

Self Cite

View full text Add to dashboard Cite

show abstract

“…Moreover, the higher levels of disability were associated with suffering from changes in the neurologist-patient relationship. Patients with migraines during the COVID-19 pandemic complained of agitation and anxiety [ 14 ]. Patients with chronic diseases suffered from changes in medical care during the COVID-19 pandemic and need frequent access to health facilities, including in-person visits, follow-ups, and treatments [ 15 ].…”

Section: Resultsmentioning

confidence: 99%

Patients’ Habits and the Role of Pharmacists and Telemedicine as Elements of a Modern Health Care System during the COVID-19 Pandemic

Grosman-Dziewiszek

Wiatrak

Jęśkowiak

et al. 2021

JCM

View full text Add to dashboard Cite

Aims/Introduction: The Polish government introduced the epidemic on 20 March 2020, after The World Health Organization (WHO) announced the new coronavirus disease (COVID-19) in January 2020. Patients’ access to specialist clinics and family medicine clinics was limited. In this situation, pharmacists were likely the first option for patient’s health information. On 18 March 2020, the National Health Fund issued modifications that increased the accessibility to primary health care such as telemedicine. The development of e-health in Poland during the COVID-19 pandemic included the implementation of electronic medical records (EDM), telemedicine development, e-prescription, and e-referrals implementation. We investigated this emergency’s effect on patients’ health habits, access to healthcare, and attitude to vaccination. Materials and methods: An anonymous study in the form of an electronic and paper questionnaire was conducted in March 2021 among 926 pharmacies patients in Poland. The content of the questionnaire included access to medical care, performing preventive examinations, implementation of e-prescriptions, patient satisfaction with telepathing, pharmaceutical care, and COVID-19 vaccination. Results: During the COVID-19 pandemic, 456 (49.2%) patients experienced worse access to a doctor. On the other hand, 483 (52.2%) patients did not perform preventive examinations during the COVID-19 pandemic. Almost half of the patients (45.4% (n = 420)) were not satisfied with the teleconsultation visit to the doctor. A total of 90% (n = 833) of the respondents do not need help in making an appointment with a doctor and buying medications prescribed by a doctor in the form of an e-prescription. In the absence of access to medical consultation, 38.2% (n = 354) of respondents choose the Internet as a source of medical advice. However, in the absence of contact with a doctor, 229 persons (24.7%) who took part in the survey consulted a pharmacist. In addition, 239 persons (25.8%) used pharmacist advice more often during the COVID-19 pandemic than before its outbreak on 12 March 2020. Moreover, 457 (49.4%) respondents are satisfied with the advice provided by pharmacists, and even 439 patients of pharmacies (47.4%) expect an increase in the scope of pharmaceutical care in the future, including medical advice provided by pharmacists. Most of the respondents, 45.6% (n = 422), want to be vaccinated in a hospital or clinic, but at the same time, for a slightly smaller number of people, 44.6% (n = 413), it has no meaning where they are will be vaccinated against COVID-19. Conclusions: Telemedicine is appreciated by patients but also has some limitations. The COVID-19 pandemic is the chance for telemedicine to transform from implementations to a routine healthcare system structure. However, some patients still need face-to-face contact with the doctor or pharmacist. Pharmacists are essential contributors to public health and play an essential role during the COVID-19 pandemic. Integration of pharmaceutical care with public health care and strong growth in the professional group of pharmacists may have optimized patient care.

show abstract

“…Depending on the personal situation of the patients, particularly related to stress, working, and quality of sleep, frequency of headache could vary differently. In association with this personal situation, it has been reported that quality of life has been reduced in patients with chronic migraine during the COVID-19 lockdown in comparison with healthy family members (controls) [15]. Despite aggravating factors such as stress, exposure to work, and poor quality of sleep, the onabotulinumtoxinA treatment presented a positive effect in the patients with the planned follow-up compared to those with involuntary delay.…”

Section: Discussionmentioning

confidence: 98%

Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown

et al. 2021

View full text Add to dashboard Cite

Background Face-to-face procedures have been postponed during COVID-19 pandemic. We aim to evaluate the impact of onabotulinumtoxinA follow-up delay in migraine during COVID-19 pandemic. Methods Subjective worsening, intensity of migraine attacks, and frequency of headache and migraine were retrospectively compared between patients with unmodified and interrupted onabotulinumtoxinA follow-up in Headache Units. Results We included 67 patients with chronic migraine or high-frequency episodic migraine under onabotulinumtoxinA treatment, 65 (97.0%) female, 44.5 ± 12.1 years old. Treatment administration was voluntarily delayed in 14 (20.9%) patients and nine (13.4%) were unable to continue follow-up. Patients with uninterrupted follow-up during lockdown presented 7.6 and 8.1 less monthly days with headache (adjusted p = 0.017) and migraine attacks (adjusted p = 0.009) compared to patients whose follow-up was interrupted, respectively. Conclusion Involuntary delay of onabotulinumtoxinA follow-up in patients with migraine due to COVID-19 pandemic was associated with a higher frequency of headache and migraine attacks. Safe administration of onabotulinumtoxinA during lockdown should be promoted.

show abstract

Life with chronic pain during COVID-19 lockdown: the case of patients with small fibre neuropathy and chronic migraine

Cited by 32 publications

References 39 publications

Lessons from lockdown — behavioural interventions in migraine

Lessons from lockdown — behavioural interventions in migraine

Patients’ Habits and the Role of Pharmacists and Telemedicine as Elements of a Modern Health Care System during the COVID-19 Pandemic

Effects of the onabotulinumtoxinA follow-up delay in migraine course during the COVID-19 lockdown

Contact Info

Product

Resources

About